Tajinder K. Singh , Daan Ties , Hilde E. Groot , Paul F.M. Krabbe , Pim van der Harst
{"title":"Measuring health-related quality of life in cardiovascular disease using a novel patient-centred and disease-specific patient-reported outcome measure","authors":"Tajinder K. Singh , Daan Ties , Hilde E. Groot , Paul F.M. Krabbe , Pim van der Harst","doi":"10.1016/j.ijcrp.2024.200357","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Assessment of health-related quality of life (HRQoL) in patients with cardiovascular disease (CVD) is impaired by limitations of current patient-reported outcome measures (PROMs). We developed the first cardiovascular disease (CVD) specific electronic PROM for which health items were derived by a fully patient-centered method. This paper reports on the measurement of HRQoL in CVD patients by a novel developed electronic patient-centred PROM based on a preference-based measurement model.</div></div><div><h3>Methods and results</h3><div>In an earlier patient-based study nine health items were selected as most important to CVD patients. These items were assessed in the novel preference-based PROM of this study. CVD patients registered with a Dutch patient organization were asked to rate their health state. We compared HRQoL between subgroups of age, gender and CVD. A total of 554 patients participated in this study. The patient reported health items “worry”, “self-reliance” and “sexuality” had the highest impact on HRQoL of CVD patients. Median HRQoL was better for men compared to woman (−17.04, IQR: 31.47 to −3.91 vs. −25.22; IQR: 42.06 to −9.53, p = 0.003). Best and worst HRQoL were observed in patients with an unknown or other CVD disease (−15.61, IQR: 28.52 to −3.91) followed by individuals with coronary artery disease (−16.99, IQR: 38.08 - 0.00) and heart failure (−24.27, IQR: 42.64 to −12.98).</div></div><div><h3>Conclusions</h3><div>This novel patient-centred, preference-based, CVD-specific PROM accurately measures HRQoL by taking individual health preferences into account and tackling limitations of current PROMs. This PROM is therefore promising to evaluate interventions and optimize personalized therapies.</div></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"24 ","pages":"Article 200357"},"PeriodicalIF":1.9000,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11720887/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cardiology Cardiovascular Risk and Prevention","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772487524001223","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Assessment of health-related quality of life (HRQoL) in patients with cardiovascular disease (CVD) is impaired by limitations of current patient-reported outcome measures (PROMs). We developed the first cardiovascular disease (CVD) specific electronic PROM for which health items were derived by a fully patient-centered method. This paper reports on the measurement of HRQoL in CVD patients by a novel developed electronic patient-centred PROM based on a preference-based measurement model.
Methods and results
In an earlier patient-based study nine health items were selected as most important to CVD patients. These items were assessed in the novel preference-based PROM of this study. CVD patients registered with a Dutch patient organization were asked to rate their health state. We compared HRQoL between subgroups of age, gender and CVD. A total of 554 patients participated in this study. The patient reported health items “worry”, “self-reliance” and “sexuality” had the highest impact on HRQoL of CVD patients. Median HRQoL was better for men compared to woman (−17.04, IQR: 31.47 to −3.91 vs. −25.22; IQR: 42.06 to −9.53, p = 0.003). Best and worst HRQoL were observed in patients with an unknown or other CVD disease (−15.61, IQR: 28.52 to −3.91) followed by individuals with coronary artery disease (−16.99, IQR: 38.08 - 0.00) and heart failure (−24.27, IQR: 42.64 to −12.98).
Conclusions
This novel patient-centred, preference-based, CVD-specific PROM accurately measures HRQoL by taking individual health preferences into account and tackling limitations of current PROMs. This PROM is therefore promising to evaluate interventions and optimize personalized therapies.